Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials

Published:2018-08 Issue:2 Volume:68 Page:763-772
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Caussy Cyrielle¹²,Reeder Scott B.³,Sirlin Claude B.⁴,Loomba Rohit¹⁵⁶

Affiliation:

1. NAFLD Research Center; Department of Medicine; University of California; San Diego La Jolla CA

2. Université Lyon 1; Hospices Civils de Lyon, Lyon France

3. Department of Radiology, Medical Physics, Biomedical Engineering, Medicine, and Emergency Medicine; University of Wisconsin-Madison; Madison WI

4. Liver Imaging Group, Department of Radiology; University of California; San Diego La Jolla CA

5. Division of Gastroenterology, Department of Medicine; University of California; San Diego La Jolla CA

6. Division of Epidemiology, Department of Family and Preventive Medicine; University of California; San Diego La Jolla CA

Funder

Atlantic Philanthropies, Inc

the John A. Hartford Foundation

National Institutes of Health

GE Healthcare

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29797/fullpdf

Reference64 articles.

1. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013

2. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

3. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

4. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies;Singh;Clin Gastroenterol Hepatol,2015

5. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015

Cited by 335 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of hepatic fat quantification across 5 T, 3 T and 1.5 T: A study on consistency and feasibility;European Journal of Radiology;2024-11

2. Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis;European Radiology;2024-09-10

3. Efficacy and safety of Huatan Qushi Huoxue Fang granules on obese non-alcoholic fatty liver disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial;2024-09-04

4. Future of U.S. living donor liver transplant: Donor and recipient criteria, transplant indications, transplant oncology, liver paired exchange, and non-directed donor graft allocation;Liver Transplantation;2024-08-23

5. HEPATOSTEATOZ DEĞERLENDİRMEDE ETKİN BİR ÖLÇEĞİN PSÖRİATİK ARTRİTLİ HASTALARDA KULLANIMI: DOKU ATENUASYON GÖRÜNTÜLEME;Kırıkkale Üniversitesi Tıp Fakültesi Dergisi;2024-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3